Director/PDMR Dealing | 23-Mar-2022 | 17:53 | RNS |
Director/PDMR Dealing | 21-Mar-2022 | 07:00 | RNS |
Pre-close Trading Update | 15-Mar-2022 | 07:00 | RNS |
New Marketing Authorisations for Aivlosin in China | 23-Feb-2022 | 07:00 | RNS |
Holding(s) in Company | 01-Feb-2022 | 13:53 | RNS |
Investor Presentation | 24-Jan-2022 | 07:00 | RNS |
Holding(s) in Company | 18-Jan-2022 | 07:01 | RNS |
Chief Executive Officer Appointment | 18-Jan-2022 | 07:00 | RNS |
Holding(s) in Company | 13-Jan-2022 | 09:29 | RNS |
Trading update, Appointment of Joint Broker & CMD | 12-Jan-2022 | 07:00 | RNS |
Holding(s) in Company | 06-Dec-2021 | 08:14 | RNS |
Board Appointment | 01-Dec-2021 | 07:00 | RNS |
Director Dealings | 30-Nov-2021 | 12:39 | RNS |
Results for the six months ended 30 September 2021 | 25-Nov-2021 | 07:00 | RNS |
Investor Presentation covering Interim Results | 23-Nov-2021 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 130.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 132.00p |
52 Week Low | 84.00p |
Volume | 10,642 |
Shares Issued | 67.74m |
Market Cap | £88.07m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 23-Sep-21 | 26-Sep-19 |
Paid | 22-Oct-21 | 16-Oct-19 |
Amount | 1.00p | 7.04p |
Time | Volume / Share Price |
16:29 | 4,550 @ 128.80p |
15:52 | 2,500 @ 128.00p |
10:02 | 7 @ 132.00p |
09:00 | 3,585 @ 128.00p |
CFO | Christopher Wilks |
CEO | David Hallas |
You are here: research